Literature DB >> 24667822

Diagnostic value of direct fluorescence antibody staining for detecting Pneumocystis jirovecii in expectorated sputum from patients with HIV infection.

Pyoeng Gyun Choe1, Yoo Min Kang, Gayeon Kim, Wan Beom Park, Sang Won Park, Hong Bin Kim, Myoung-Don Oh, Eui Chong Kim, Nam Joong Kim.   

Abstract

Direct fluorescent antibody (DFA) staining of induced sputum is frequently used to diagnose Pneumocystis pneumonia (PCP) in patients infected with human immunodeficiency virus, although induction can provoke nausea and bronchospasm. Since the diagnostic value of expectorated sputum examined with DFA stain has not been well evaluated, we reviewed the medical records of HIV-infected patients who were clinically diagnosed as having PCP between 1999 and 2011. Over this 13-year period, we found 76 patients whose records included the results of DFA staining of expectorated sputum and noted that 42 (55.3%) were positive. Polymerase chain reaction to detect Pneumocystis in the sputum of 65 of the patients resulted in the finding of 43 (66.2%) who were positive. Our findings suggest that DFA staining of expectorated sputum could be a useful initial diagnostic method in HIV-infected patients with PCP.

Entities:  

Keywords:  HIV; fluorescent antibody technique; pneumocystis; sputum

Mesh:

Year:  2014        PMID: 24667822     DOI: 10.1093/mmy/myu002

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

Review 1.  Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized.

Authors:  David W Denning
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-05       Impact factor: 6.237

2.  Profile of pneumocystis infection in a tertiary care institute in North India.

Authors:  Ravinder Kaur; Pragyan Swagatika Panda; Richa Dewan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2016 Jul-Dec

Review 3.  Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.

Authors:  David W Denning; David S Perlin; Eavan G Muldoon; Arnaldo Lopes Colombo; Arunaloke Chakrabarti; Malcolm D Richardson; Tania C Sorrell
Journal:  Emerg Infect Dis       Date:  2017-02-15       Impact factor: 6.883

4.  Diagnosis of Pneumocystis jirovecii Pneumonia in Pediatric Patients in Serbia, Greece, and Romania. Current Status and Challenges for Collaboration.

Authors:  Valentina Arsić Arsenijevic; Timoleon-Achilleas Vyzantiadis; Mihai Mares; Suzana Otasevic; Athanasios Tragiannidis; Dragana Janic
Journal:  J Fungi (Basel)       Date:  2020-04-17

5.  Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens.

Authors:  Bei Jia; Robert Lovari; Heather Miller; David Metzgar; Christian Massire; Heather Carolan; Donna Toleno; Franco D'Alessio; Richard Rothman; Lawrence B Blyn; Sean X Zhang
Journal:  Diagn Microbiol Infect Dis       Date:  2020-01-15       Impact factor: 2.803

6.  The diagnostic challenge of pneumocystis pneumonia and COVID-19 co-infection in HIV.

Authors:  Alistair G B Broadhurst; Usha Lalla; Jantjie J Taljaard; Elizabeth H Louw; Coenraad F N Koegelenberg; Brian W Allwood
Journal:  Respirol Case Rep       Date:  2021-02-22

7.  [Adequacy to diagnostic recommendations in patients with Pneumocystis jirovecii pneumonia treated with intravenous pentamidine].

Authors:  L Cantarelli; F Gutiérrez Nicolás; G J Nazco Casariego; S García Gil
Journal:  Rev Esp Quimioter       Date:  2021-12-01       Impact factor: 1.553

8.  Epidemiology of fungal diseases in Africa: A review of diagnostic drivers.

Authors:  Felix Bongomin; Samuel Adetona Fayemiwo
Journal:  Curr Med Mycol       Date:  2021-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.